R-pharm
Clinical trials sponsored by R-pharm, explained in plain language.
-
New cancer drug enters final testing against standard treatment
Disease control OngoingThis study is testing if a new drug called RPH-002 works as well as the established drug Erbitux (cetuximab) for people with advanced head and neck cancer that has spread or returned. Both drugs are given with standard chemotherapy. The main goal is to see if the new drug shrinks…
Phase: PHASE3 • Sponsor: R-Pharm • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for advanced breast cancer? trial tests potential cheaper alternative
Disease control OngoingThis study is testing if a new drug called RPH-051 works as well as the established drug Perjeta (pertuzumab) for controlling advanced HER2-positive breast cancer. About 246 patients with metastatic or locally advanced cancer will receive either RPH-051 or Perjeta, combined with …
Phase: PHASE3 • Sponsor: R-Pharm • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC